Global Rapid Antibody and Antigen Testing Kit Market
Global Rapid Antibody and Antigen Testing Kit Market

Rapid Antibody and Antigen Testing Kit Comprehensive Study by Components (50 Strips /Tests Per Box, 1x Test Cassette, 1x Desiccant Pouch, 25x Disposable Pipettes, Sample Diluent), Disease (Autoimmune Diseases, Tropical Diseases, Liver Diseases, Sexually Transmitted Diseases), Sample (Serum, Plasma, Whole Blood), End Use (Hospitals, Clinics, Diagnostics Laboratory, Home Care, Others) Players and Region - Global Market Outlook to 2025

Rapid Antibody and Antigen Testing Kit Market Segmented into XX Submarkets. | Forecast Years: 2020- 2025  

Sep 2020 Edition 214 Pages 214 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Rapid Antibody and Antigen Testing Kit Market Definition
Rapid antibody and antigen testing kit are used for diagnosing any kind of respiratory bacteria and diseases associated with it, these tests detect the specific viral infection giving quick results. The antigen testa is done on the nasal swab and antibody tests are done to detect the antibodies developing in the body through the immune system in response to the active infection. The rapid antibody and antigen testing kit are used in hospitals, clinics, diagnostics laboratories, and even at home care settings. The kit consists of testing material like strips /tests per box, 1x test cassette, 1x desiccant pouch, 25x disposable pipettes, sample diluent along with guiding instruction for the testing. With the help of these components, serum, plasma, or whole blood sample is taken for the testing showing results in 10-15 minutes.

The market study is broken down and major geographies with country level splits.

Abbott Laboratories (United States), Thermo Fisher Scientific (United States), BioMedomics, Inc. (United States), SD Biosensor, Inc. (South Korea), Oxford Biomedica (United Kingdom), BioLab Sciences (United States), CTK Biotech, Inc. (United States), Roche Holding AG (Switzerland), R-Biopharm AG (Germany) and Celltrion (South Korea) are some of the key players that are part of study coverage.

Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Rapid Antibody and Antigen Testing Kit market by Type, Application and Region.

On the basis of geography, the market of Rapid Antibody and Antigen Testing Kit has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Components, the sub-segment i.e. 50 Strips /Tests Per Box will boost the Rapid Antibody and Antigen Testing Kit market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Disease, the sub-segment i.e. Autoimmune Diseases will boost the Rapid Antibody and Antigen Testing Kit market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Sample, the sub-segment i.e. Serum will boost the Rapid Antibody and Antigen Testing Kit market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End Use, the sub-segment i.e. Hospitals will boost the Rapid Antibody and Antigen Testing Kit market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Leaders and their expansionary development strategies
On 8th April 2020, BioLab Sciences, a regenerative biotechnology company, announced they are now distributing tests to detect antibodies specific to 2019n-CoV in humans. The test devices complete the screening using a blood sample from a finger prick and produce results in 10 minutes. and On 12th March 2020, CTK Biotech, Inc. launched Test kits for COVID-19. CTK collaborated with its partners in China, and launched two diagnostic tests for this virus, both a real-time PCR based nucleic acid detection kit and a serological rapid screening test, for the International market.
On 26th August 2020, Abbott announced that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for its BinaxNOW COVID-19 Ag Card rapid test for detection of COVID-19 infection. Abbott will sell this test for a 5US Dollar,15-minute, easy-to-use COVID-19 antigen test receives FDA emergency use authorization; mobile app displays test results to help our return to daily life; ramping production to 50 million tests a month. and On 1st September 2020, Roche announced that it will launch a SARS-CoV-2 Rapid Antigen Test, in late September, for markets accepting the CE Mark. Roche also intends to file for Emergency Use Authorisation (EUA) to the U.S. Food and Drug Administration (FDA).
"The U.S. Food and Drug Administration has issued the first emergency use authorization (EUA) for a COVID-19 antigen test, a new category of tests for use in the ongoing pandemic. These diagnostic tests quickly detect fragments of proteins found on or within the virus by testing samples collected from the nasal cavity using swabs. The EUA was issued to Quidel Corporation for the Sofia 2 SARS Antigen FIA. This test is authorized for use in high and moderate complexity laboratories certified by Clinical Laboratory Improvement Amendments (CLIA), as well as for point-of-care testing by facilities operating under a CLIA Certificate of Waiver."

Market Trend
  • Continuous Research and Development in the Antibody and Antigen Testing

Market Drivers
  • Increasing Number of COVID-19 Cases in Various Region of the World
  • Need for the Rapid Diagnostics Kits for Faster Treatment
  • Emerging New Kinds of Deadly Diseases

Opportunities
  • Surging Government Intervention and Investment to Diagnose Any Kind of Autoimmune Disease will Boost the Rapid Antibody and Antigen Testing Kit Market

Restraints
  • Less Skilled Professional for the Rapid Antibody and Antigen Testing Kit Operation

Challenges
  • Low-Quality False Result Showing Rapid Antibody and Antigen Testing Kit Players in the Market


Key Target Audience
Rapid Antibody and Antigen Testing Kit Manufacturers, Rapid Antibody and Antigen Testing Kit Distributors and Suppliers, Hospital Industry Association, Research and Development Institutes, Potential Investors, Regulatory Bodies and Others

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Components
  • 50 Strips /Tests Per Box
  • 1x Test Cassette
  • 1x Desiccant Pouch
  • 25x Disposable Pipettes
  • Sample Diluent

By Disease
  • Autoimmune Diseases
  • Tropical Diseases
  • Liver Diseases
  • Sexually Transmitted Diseases

By Sample
  • Serum
  • Plasma
  • Whole Blood

By End Use
  • Hospitals
  • Clinics
  • Diagnostics Laboratory
  • Home Care
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Number of COVID-19 Cases in Various Region of the World
      • 3.2.2. Need for the Rapid Diagnostics Kits for Faster Treatment
      • 3.2.3. Emerging New Kinds of Deadly Diseases
    • 3.3. Market Challenges
      • 3.3.1. Low-Quality False Result Showing Rapid Antibody and Antigen Testing Kit Players in the Market
    • 3.4. Market Trends
      • 3.4.1. Continuous Research and Development in the Antibody and Antigen Testing
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Rapid Antibody and Antigen Testing Kit, by Components, Disease, Sample, End Use and Region (value) (2014-2019)
    • 5.1. Introduction
    • 5.2. Global Rapid Antibody and Antigen Testing Kit (Value)
      • 5.2.1. Global Rapid Antibody and Antigen Testing Kit by: Components (Value)
        • 5.2.1.1. 50 Strips /Tests Per Box
        • 5.2.1.2. 1x Test Cassette
        • 5.2.1.3. 1x Desiccant Pouch
        • 5.2.1.4. 25x Disposable Pipettes
        • 5.2.1.5. Sample Diluent
      • 5.2.2. Global Rapid Antibody and Antigen Testing Kit by: Disease (Value)
        • 5.2.2.1. Autoimmune Diseases
        • 5.2.2.2. Tropical Diseases
        • 5.2.2.3. Liver Diseases
        • 5.2.2.4. Sexually Transmitted Diseases
      • 5.2.3. Global Rapid Antibody and Antigen Testing Kit by: Sample (Value)
        • 5.2.3.1. Serum
        • 5.2.3.2. Plasma
        • 5.2.3.3. Whole Blood
      • 5.2.4. Global Rapid Antibody and Antigen Testing Kit by: End Use (Value)
        • 5.2.4.1. Hospitals
        • 5.2.4.2. Clinics
        • 5.2.4.3. Diagnostics Laboratory
        • 5.2.4.4. Home Care
        • 5.2.4.5. Others
      • 5.2.5. Global Rapid Antibody and Antigen Testing Kit Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Rapid Antibody and Antigen Testing Kit: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2019)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Abbott Laboratories (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Thermo Fisher Scientific (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. BioMedomics, Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. SD Biosensor, Inc. (South Korea)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Oxford Biomedica (United Kingdom)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. BioLab Sciences (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. CTK Biotech, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Roche Holding AG (Switzerland)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. R-Biopharm AG (Germany)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Celltrion (South Korea)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Rapid Antibody and Antigen Testing Kit Sale, by Components, Disease, Sample, End Use and Region (value) (2020-2025)
    • 7.1. Introduction
    • 7.2. Global Rapid Antibody and Antigen Testing Kit (Value)
      • 7.2.1. Global Rapid Antibody and Antigen Testing Kit by: Components (Value)
        • 7.2.1.1. 50 Strips /Tests Per Box
        • 7.2.1.2. 1x Test Cassette
        • 7.2.1.3. 1x Desiccant Pouch
        • 7.2.1.4. 25x Disposable Pipettes
        • 7.2.1.5. Sample Diluent
      • 7.2.2. Global Rapid Antibody and Antigen Testing Kit by: Disease (Value)
        • 7.2.2.1. Autoimmune Diseases
        • 7.2.2.2. Tropical Diseases
        • 7.2.2.3. Liver Diseases
        • 7.2.2.4. Sexually Transmitted Diseases
      • 7.2.3. Global Rapid Antibody and Antigen Testing Kit by: Sample (Value)
        • 7.2.3.1. Serum
        • 7.2.3.2. Plasma
        • 7.2.3.3. Whole Blood
      • 7.2.4. Global Rapid Antibody and Antigen Testing Kit by: End Use (Value)
        • 7.2.4.1. Hospitals
        • 7.2.4.2. Clinics
        • 7.2.4.3. Diagnostics Laboratory
        • 7.2.4.4. Home Care
        • 7.2.4.5. Others
      • 7.2.5. Global Rapid Antibody and Antigen Testing Kit Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Rapid Antibody and Antigen Testing Kit: by Components(USD Million)
  • Table 2. Rapid Antibody and Antigen Testing Kit 50 Strips /Tests Per Box , by Region USD Million (2014-2019)
  • Table 3. Rapid Antibody and Antigen Testing Kit 1x Test Cassette , by Region USD Million (2014-2019)
  • Table 4. Rapid Antibody and Antigen Testing Kit 1x Desiccant Pouch , by Region USD Million (2014-2019)
  • Table 5. Rapid Antibody and Antigen Testing Kit 25x Disposable Pipettes , by Region USD Million (2014-2019)
  • Table 6. Rapid Antibody and Antigen Testing Kit Sample Diluent , by Region USD Million (2014-2019)
  • Table 7. Rapid Antibody and Antigen Testing Kit: by Disease(USD Million)
  • Table 8. Rapid Antibody and Antigen Testing Kit Autoimmune Diseases , by Region USD Million (2014-2019)
  • Table 9. Rapid Antibody and Antigen Testing Kit Tropical Diseases , by Region USD Million (2014-2019)
  • Table 10. Rapid Antibody and Antigen Testing Kit Liver Diseases , by Region USD Million (2014-2019)
  • Table 11. Rapid Antibody and Antigen Testing Kit Sexually Transmitted Diseases , by Region USD Million (2014-2019)
  • Table 12. Rapid Antibody and Antigen Testing Kit: by Sample(USD Million)
  • Table 13. Rapid Antibody and Antigen Testing Kit Serum , by Region USD Million (2014-2019)
  • Table 14. Rapid Antibody and Antigen Testing Kit Plasma , by Region USD Million (2014-2019)
  • Table 15. Rapid Antibody and Antigen Testing Kit Whole Blood , by Region USD Million (2014-2019)
  • Table 16. Rapid Antibody and Antigen Testing Kit: by End Use(USD Million)
  • Table 17. Rapid Antibody and Antigen Testing Kit Hospitals , by Region USD Million (2014-2019)
  • Table 18. Rapid Antibody and Antigen Testing Kit Clinics , by Region USD Million (2014-2019)
  • Table 19. Rapid Antibody and Antigen Testing Kit Diagnostics Laboratory , by Region USD Million (2014-2019)
  • Table 20. Rapid Antibody and Antigen Testing Kit Home Care , by Region USD Million (2014-2019)
  • Table 21. Rapid Antibody and Antigen Testing Kit Others , by Region USD Million (2014-2019)
  • Table 22. South America Rapid Antibody and Antigen Testing Kit, by Country USD Million (2014-2019)
  • Table 23. South America Rapid Antibody and Antigen Testing Kit, by Components USD Million (2014-2019)
  • Table 24. South America Rapid Antibody and Antigen Testing Kit, by Disease USD Million (2014-2019)
  • Table 25. South America Rapid Antibody and Antigen Testing Kit, by Sample USD Million (2014-2019)
  • Table 26. South America Rapid Antibody and Antigen Testing Kit, by End Use USD Million (2014-2019)
  • Table 27. Brazil Rapid Antibody and Antigen Testing Kit, by Components USD Million (2014-2019)
  • Table 28. Brazil Rapid Antibody and Antigen Testing Kit, by Disease USD Million (2014-2019)
  • Table 29. Brazil Rapid Antibody and Antigen Testing Kit, by Sample USD Million (2014-2019)
  • Table 30. Brazil Rapid Antibody and Antigen Testing Kit, by End Use USD Million (2014-2019)
  • Table 31. Argentina Rapid Antibody and Antigen Testing Kit, by Components USD Million (2014-2019)
  • Table 32. Argentina Rapid Antibody and Antigen Testing Kit, by Disease USD Million (2014-2019)
  • Table 33. Argentina Rapid Antibody and Antigen Testing Kit, by Sample USD Million (2014-2019)
  • Table 34. Argentina Rapid Antibody and Antigen Testing Kit, by End Use USD Million (2014-2019)
  • Table 35. Rest of South America Rapid Antibody and Antigen Testing Kit, by Components USD Million (2014-2019)
  • Table 36. Rest of South America Rapid Antibody and Antigen Testing Kit, by Disease USD Million (2014-2019)
  • Table 37. Rest of South America Rapid Antibody and Antigen Testing Kit, by Sample USD Million (2014-2019)
  • Table 38. Rest of South America Rapid Antibody and Antigen Testing Kit, by End Use USD Million (2014-2019)
  • Table 39. Asia Pacific Rapid Antibody and Antigen Testing Kit, by Country USD Million (2014-2019)
  • Table 40. Asia Pacific Rapid Antibody and Antigen Testing Kit, by Components USD Million (2014-2019)
  • Table 41. Asia Pacific Rapid Antibody and Antigen Testing Kit, by Disease USD Million (2014-2019)
  • Table 42. Asia Pacific Rapid Antibody and Antigen Testing Kit, by Sample USD Million (2014-2019)
  • Table 43. Asia Pacific Rapid Antibody and Antigen Testing Kit, by End Use USD Million (2014-2019)
  • Table 44. China Rapid Antibody and Antigen Testing Kit, by Components USD Million (2014-2019)
  • Table 45. China Rapid Antibody and Antigen Testing Kit, by Disease USD Million (2014-2019)
  • Table 46. China Rapid Antibody and Antigen Testing Kit, by Sample USD Million (2014-2019)
  • Table 47. China Rapid Antibody and Antigen Testing Kit, by End Use USD Million (2014-2019)
  • Table 48. Japan Rapid Antibody and Antigen Testing Kit, by Components USD Million (2014-2019)
  • Table 49. Japan Rapid Antibody and Antigen Testing Kit, by Disease USD Million (2014-2019)
  • Table 50. Japan Rapid Antibody and Antigen Testing Kit, by Sample USD Million (2014-2019)
  • Table 51. Japan Rapid Antibody and Antigen Testing Kit, by End Use USD Million (2014-2019)
  • Table 52. India Rapid Antibody and Antigen Testing Kit, by Components USD Million (2014-2019)
  • Table 53. India Rapid Antibody and Antigen Testing Kit, by Disease USD Million (2014-2019)
  • Table 54. India Rapid Antibody and Antigen Testing Kit, by Sample USD Million (2014-2019)
  • Table 55. India Rapid Antibody and Antigen Testing Kit, by End Use USD Million (2014-2019)
  • Table 56. South Korea Rapid Antibody and Antigen Testing Kit, by Components USD Million (2014-2019)
  • Table 57. South Korea Rapid Antibody and Antigen Testing Kit, by Disease USD Million (2014-2019)
  • Table 58. South Korea Rapid Antibody and Antigen Testing Kit, by Sample USD Million (2014-2019)
  • Table 59. South Korea Rapid Antibody and Antigen Testing Kit, by End Use USD Million (2014-2019)
  • Table 60. Taiwan Rapid Antibody and Antigen Testing Kit, by Components USD Million (2014-2019)
  • Table 61. Taiwan Rapid Antibody and Antigen Testing Kit, by Disease USD Million (2014-2019)
  • Table 62. Taiwan Rapid Antibody and Antigen Testing Kit, by Sample USD Million (2014-2019)
  • Table 63. Taiwan Rapid Antibody and Antigen Testing Kit, by End Use USD Million (2014-2019)
  • Table 64. Australia Rapid Antibody and Antigen Testing Kit, by Components USD Million (2014-2019)
  • Table 65. Australia Rapid Antibody and Antigen Testing Kit, by Disease USD Million (2014-2019)
  • Table 66. Australia Rapid Antibody and Antigen Testing Kit, by Sample USD Million (2014-2019)
  • Table 67. Australia Rapid Antibody and Antigen Testing Kit, by End Use USD Million (2014-2019)
  • Table 68. Rest of Asia-Pacific Rapid Antibody and Antigen Testing Kit, by Components USD Million (2014-2019)
  • Table 69. Rest of Asia-Pacific Rapid Antibody and Antigen Testing Kit, by Disease USD Million (2014-2019)
  • Table 70. Rest of Asia-Pacific Rapid Antibody and Antigen Testing Kit, by Sample USD Million (2014-2019)
  • Table 71. Rest of Asia-Pacific Rapid Antibody and Antigen Testing Kit, by End Use USD Million (2014-2019)
  • Table 72. Europe Rapid Antibody and Antigen Testing Kit, by Country USD Million (2014-2019)
  • Table 73. Europe Rapid Antibody and Antigen Testing Kit, by Components USD Million (2014-2019)
  • Table 74. Europe Rapid Antibody and Antigen Testing Kit, by Disease USD Million (2014-2019)
  • Table 75. Europe Rapid Antibody and Antigen Testing Kit, by Sample USD Million (2014-2019)
  • Table 76. Europe Rapid Antibody and Antigen Testing Kit, by End Use USD Million (2014-2019)
  • Table 77. Germany Rapid Antibody and Antigen Testing Kit, by Components USD Million (2014-2019)
  • Table 78. Germany Rapid Antibody and Antigen Testing Kit, by Disease USD Million (2014-2019)
  • Table 79. Germany Rapid Antibody and Antigen Testing Kit, by Sample USD Million (2014-2019)
  • Table 80. Germany Rapid Antibody and Antigen Testing Kit, by End Use USD Million (2014-2019)
  • Table 81. France Rapid Antibody and Antigen Testing Kit, by Components USD Million (2014-2019)
  • Table 82. France Rapid Antibody and Antigen Testing Kit, by Disease USD Million (2014-2019)
  • Table 83. France Rapid Antibody and Antigen Testing Kit, by Sample USD Million (2014-2019)
  • Table 84. France Rapid Antibody and Antigen Testing Kit, by End Use USD Million (2014-2019)
  • Table 85. Italy Rapid Antibody and Antigen Testing Kit, by Components USD Million (2014-2019)
  • Table 86. Italy Rapid Antibody and Antigen Testing Kit, by Disease USD Million (2014-2019)
  • Table 87. Italy Rapid Antibody and Antigen Testing Kit, by Sample USD Million (2014-2019)
  • Table 88. Italy Rapid Antibody and Antigen Testing Kit, by End Use USD Million (2014-2019)
  • Table 89. United Kingdom Rapid Antibody and Antigen Testing Kit, by Components USD Million (2014-2019)
  • Table 90. United Kingdom Rapid Antibody and Antigen Testing Kit, by Disease USD Million (2014-2019)
  • Table 91. United Kingdom Rapid Antibody and Antigen Testing Kit, by Sample USD Million (2014-2019)
  • Table 92. United Kingdom Rapid Antibody and Antigen Testing Kit, by End Use USD Million (2014-2019)
  • Table 93. Netherlands Rapid Antibody and Antigen Testing Kit, by Components USD Million (2014-2019)
  • Table 94. Netherlands Rapid Antibody and Antigen Testing Kit, by Disease USD Million (2014-2019)
  • Table 95. Netherlands Rapid Antibody and Antigen Testing Kit, by Sample USD Million (2014-2019)
  • Table 96. Netherlands Rapid Antibody and Antigen Testing Kit, by End Use USD Million (2014-2019)
  • Table 97. Rest of Europe Rapid Antibody and Antigen Testing Kit, by Components USD Million (2014-2019)
  • Table 98. Rest of Europe Rapid Antibody and Antigen Testing Kit, by Disease USD Million (2014-2019)
  • Table 99. Rest of Europe Rapid Antibody and Antigen Testing Kit, by Sample USD Million (2014-2019)
  • Table 100. Rest of Europe Rapid Antibody and Antigen Testing Kit, by End Use USD Million (2014-2019)
  • Table 101. MEA Rapid Antibody and Antigen Testing Kit, by Country USD Million (2014-2019)
  • Table 102. MEA Rapid Antibody and Antigen Testing Kit, by Components USD Million (2014-2019)
  • Table 103. MEA Rapid Antibody and Antigen Testing Kit, by Disease USD Million (2014-2019)
  • Table 104. MEA Rapid Antibody and Antigen Testing Kit, by Sample USD Million (2014-2019)
  • Table 105. MEA Rapid Antibody and Antigen Testing Kit, by End Use USD Million (2014-2019)
  • Table 106. Middle East Rapid Antibody and Antigen Testing Kit, by Components USD Million (2014-2019)
  • Table 107. Middle East Rapid Antibody and Antigen Testing Kit, by Disease USD Million (2014-2019)
  • Table 108. Middle East Rapid Antibody and Antigen Testing Kit, by Sample USD Million (2014-2019)
  • Table 109. Middle East Rapid Antibody and Antigen Testing Kit, by End Use USD Million (2014-2019)
  • Table 110. Africa Rapid Antibody and Antigen Testing Kit, by Components USD Million (2014-2019)
  • Table 111. Africa Rapid Antibody and Antigen Testing Kit, by Disease USD Million (2014-2019)
  • Table 112. Africa Rapid Antibody and Antigen Testing Kit, by Sample USD Million (2014-2019)
  • Table 113. Africa Rapid Antibody and Antigen Testing Kit, by End Use USD Million (2014-2019)
  • Table 114. North America Rapid Antibody and Antigen Testing Kit, by Country USD Million (2014-2019)
  • Table 115. North America Rapid Antibody and Antigen Testing Kit, by Components USD Million (2014-2019)
  • Table 116. North America Rapid Antibody and Antigen Testing Kit, by Disease USD Million (2014-2019)
  • Table 117. North America Rapid Antibody and Antigen Testing Kit, by Sample USD Million (2014-2019)
  • Table 118. North America Rapid Antibody and Antigen Testing Kit, by End Use USD Million (2014-2019)
  • Table 119. United States Rapid Antibody and Antigen Testing Kit, by Components USD Million (2014-2019)
  • Table 120. United States Rapid Antibody and Antigen Testing Kit, by Disease USD Million (2014-2019)
  • Table 121. United States Rapid Antibody and Antigen Testing Kit, by Sample USD Million (2014-2019)
  • Table 122. United States Rapid Antibody and Antigen Testing Kit, by End Use USD Million (2014-2019)
  • Table 123. Canada Rapid Antibody and Antigen Testing Kit, by Components USD Million (2014-2019)
  • Table 124. Canada Rapid Antibody and Antigen Testing Kit, by Disease USD Million (2014-2019)
  • Table 125. Canada Rapid Antibody and Antigen Testing Kit, by Sample USD Million (2014-2019)
  • Table 126. Canada Rapid Antibody and Antigen Testing Kit, by End Use USD Million (2014-2019)
  • Table 127. Mexico Rapid Antibody and Antigen Testing Kit, by Components USD Million (2014-2019)
  • Table 128. Mexico Rapid Antibody and Antigen Testing Kit, by Disease USD Million (2014-2019)
  • Table 129. Mexico Rapid Antibody and Antigen Testing Kit, by Sample USD Million (2014-2019)
  • Table 130. Mexico Rapid Antibody and Antigen Testing Kit, by End Use USD Million (2014-2019)
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Rapid Antibody and Antigen Testing Kit: by Components(USD Million)
  • Table 142. Rapid Antibody and Antigen Testing Kit 50 Strips /Tests Per Box , by Region USD Million (2020-2025)
  • Table 143. Rapid Antibody and Antigen Testing Kit 1x Test Cassette , by Region USD Million (2020-2025)
  • Table 144. Rapid Antibody and Antigen Testing Kit 1x Desiccant Pouch , by Region USD Million (2020-2025)
  • Table 145. Rapid Antibody and Antigen Testing Kit 25x Disposable Pipettes , by Region USD Million (2020-2025)
  • Table 146. Rapid Antibody and Antigen Testing Kit Sample Diluent , by Region USD Million (2020-2025)
  • Table 147. Rapid Antibody and Antigen Testing Kit: by Disease(USD Million)
  • Table 148. Rapid Antibody and Antigen Testing Kit Autoimmune Diseases , by Region USD Million (2020-2025)
  • Table 149. Rapid Antibody and Antigen Testing Kit Tropical Diseases , by Region USD Million (2020-2025)
  • Table 150. Rapid Antibody and Antigen Testing Kit Liver Diseases , by Region USD Million (2020-2025)
  • Table 151. Rapid Antibody and Antigen Testing Kit Sexually Transmitted Diseases , by Region USD Million (2020-2025)
  • Table 152. Rapid Antibody and Antigen Testing Kit: by Sample(USD Million)
  • Table 153. Rapid Antibody and Antigen Testing Kit Serum , by Region USD Million (2020-2025)
  • Table 154. Rapid Antibody and Antigen Testing Kit Plasma , by Region USD Million (2020-2025)
  • Table 155. Rapid Antibody and Antigen Testing Kit Whole Blood , by Region USD Million (2020-2025)
  • Table 156. Rapid Antibody and Antigen Testing Kit: by End Use(USD Million)
  • Table 157. Rapid Antibody and Antigen Testing Kit Hospitals , by Region USD Million (2020-2025)
  • Table 158. Rapid Antibody and Antigen Testing Kit Clinics , by Region USD Million (2020-2025)
  • Table 159. Rapid Antibody and Antigen Testing Kit Diagnostics Laboratory , by Region USD Million (2020-2025)
  • Table 160. Rapid Antibody and Antigen Testing Kit Home Care , by Region USD Million (2020-2025)
  • Table 161. Rapid Antibody and Antigen Testing Kit Others , by Region USD Million (2020-2025)
  • Table 162. South America Rapid Antibody and Antigen Testing Kit, by Country USD Million (2020-2025)
  • Table 163. South America Rapid Antibody and Antigen Testing Kit, by Components USD Million (2020-2025)
  • Table 164. South America Rapid Antibody and Antigen Testing Kit, by Disease USD Million (2020-2025)
  • Table 165. South America Rapid Antibody and Antigen Testing Kit, by Sample USD Million (2020-2025)
  • Table 166. South America Rapid Antibody and Antigen Testing Kit, by End Use USD Million (2020-2025)
  • Table 167. Brazil Rapid Antibody and Antigen Testing Kit, by Components USD Million (2020-2025)
  • Table 168. Brazil Rapid Antibody and Antigen Testing Kit, by Disease USD Million (2020-2025)
  • Table 169. Brazil Rapid Antibody and Antigen Testing Kit, by Sample USD Million (2020-2025)
  • Table 170. Brazil Rapid Antibody and Antigen Testing Kit, by End Use USD Million (2020-2025)
  • Table 171. Argentina Rapid Antibody and Antigen Testing Kit, by Components USD Million (2020-2025)
  • Table 172. Argentina Rapid Antibody and Antigen Testing Kit, by Disease USD Million (2020-2025)
  • Table 173. Argentina Rapid Antibody and Antigen Testing Kit, by Sample USD Million (2020-2025)
  • Table 174. Argentina Rapid Antibody and Antigen Testing Kit, by End Use USD Million (2020-2025)
  • Table 175. Rest of South America Rapid Antibody and Antigen Testing Kit, by Components USD Million (2020-2025)
  • Table 176. Rest of South America Rapid Antibody and Antigen Testing Kit, by Disease USD Million (2020-2025)
  • Table 177. Rest of South America Rapid Antibody and Antigen Testing Kit, by Sample USD Million (2020-2025)
  • Table 178. Rest of South America Rapid Antibody and Antigen Testing Kit, by End Use USD Million (2020-2025)
  • Table 179. Asia Pacific Rapid Antibody and Antigen Testing Kit, by Country USD Million (2020-2025)
  • Table 180. Asia Pacific Rapid Antibody and Antigen Testing Kit, by Components USD Million (2020-2025)
  • Table 181. Asia Pacific Rapid Antibody and Antigen Testing Kit, by Disease USD Million (2020-2025)
  • Table 182. Asia Pacific Rapid Antibody and Antigen Testing Kit, by Sample USD Million (2020-2025)
  • Table 183. Asia Pacific Rapid Antibody and Antigen Testing Kit, by End Use USD Million (2020-2025)
  • Table 184. China Rapid Antibody and Antigen Testing Kit, by Components USD Million (2020-2025)
  • Table 185. China Rapid Antibody and Antigen Testing Kit, by Disease USD Million (2020-2025)
  • Table 186. China Rapid Antibody and Antigen Testing Kit, by Sample USD Million (2020-2025)
  • Table 187. China Rapid Antibody and Antigen Testing Kit, by End Use USD Million (2020-2025)
  • Table 188. Japan Rapid Antibody and Antigen Testing Kit, by Components USD Million (2020-2025)
  • Table 189. Japan Rapid Antibody and Antigen Testing Kit, by Disease USD Million (2020-2025)
  • Table 190. Japan Rapid Antibody and Antigen Testing Kit, by Sample USD Million (2020-2025)
  • Table 191. Japan Rapid Antibody and Antigen Testing Kit, by End Use USD Million (2020-2025)
  • Table 192. India Rapid Antibody and Antigen Testing Kit, by Components USD Million (2020-2025)
  • Table 193. India Rapid Antibody and Antigen Testing Kit, by Disease USD Million (2020-2025)
  • Table 194. India Rapid Antibody and Antigen Testing Kit, by Sample USD Million (2020-2025)
  • Table 195. India Rapid Antibody and Antigen Testing Kit, by End Use USD Million (2020-2025)
  • Table 196. South Korea Rapid Antibody and Antigen Testing Kit, by Components USD Million (2020-2025)
  • Table 197. South Korea Rapid Antibody and Antigen Testing Kit, by Disease USD Million (2020-2025)
  • Table 198. South Korea Rapid Antibody and Antigen Testing Kit, by Sample USD Million (2020-2025)
  • Table 199. South Korea Rapid Antibody and Antigen Testing Kit, by End Use USD Million (2020-2025)
  • Table 200. Taiwan Rapid Antibody and Antigen Testing Kit, by Components USD Million (2020-2025)
  • Table 201. Taiwan Rapid Antibody and Antigen Testing Kit, by Disease USD Million (2020-2025)
  • Table 202. Taiwan Rapid Antibody and Antigen Testing Kit, by Sample USD Million (2020-2025)
  • Table 203. Taiwan Rapid Antibody and Antigen Testing Kit, by End Use USD Million (2020-2025)
  • Table 204. Australia Rapid Antibody and Antigen Testing Kit, by Components USD Million (2020-2025)
  • Table 205. Australia Rapid Antibody and Antigen Testing Kit, by Disease USD Million (2020-2025)
  • Table 206. Australia Rapid Antibody and Antigen Testing Kit, by Sample USD Million (2020-2025)
  • Table 207. Australia Rapid Antibody and Antigen Testing Kit, by End Use USD Million (2020-2025)
  • Table 208. Rest of Asia-Pacific Rapid Antibody and Antigen Testing Kit, by Components USD Million (2020-2025)
  • Table 209. Rest of Asia-Pacific Rapid Antibody and Antigen Testing Kit, by Disease USD Million (2020-2025)
  • Table 210. Rest of Asia-Pacific Rapid Antibody and Antigen Testing Kit, by Sample USD Million (2020-2025)
  • Table 211. Rest of Asia-Pacific Rapid Antibody and Antigen Testing Kit, by End Use USD Million (2020-2025)
  • Table 212. Europe Rapid Antibody and Antigen Testing Kit, by Country USD Million (2020-2025)
  • Table 213. Europe Rapid Antibody and Antigen Testing Kit, by Components USD Million (2020-2025)
  • Table 214. Europe Rapid Antibody and Antigen Testing Kit, by Disease USD Million (2020-2025)
  • Table 215. Europe Rapid Antibody and Antigen Testing Kit, by Sample USD Million (2020-2025)
  • Table 216. Europe Rapid Antibody and Antigen Testing Kit, by End Use USD Million (2020-2025)
  • Table 217. Germany Rapid Antibody and Antigen Testing Kit, by Components USD Million (2020-2025)
  • Table 218. Germany Rapid Antibody and Antigen Testing Kit, by Disease USD Million (2020-2025)
  • Table 219. Germany Rapid Antibody and Antigen Testing Kit, by Sample USD Million (2020-2025)
  • Table 220. Germany Rapid Antibody and Antigen Testing Kit, by End Use USD Million (2020-2025)
  • Table 221. France Rapid Antibody and Antigen Testing Kit, by Components USD Million (2020-2025)
  • Table 222. France Rapid Antibody and Antigen Testing Kit, by Disease USD Million (2020-2025)
  • Table 223. France Rapid Antibody and Antigen Testing Kit, by Sample USD Million (2020-2025)
  • Table 224. France Rapid Antibody and Antigen Testing Kit, by End Use USD Million (2020-2025)
  • Table 225. Italy Rapid Antibody and Antigen Testing Kit, by Components USD Million (2020-2025)
  • Table 226. Italy Rapid Antibody and Antigen Testing Kit, by Disease USD Million (2020-2025)
  • Table 227. Italy Rapid Antibody and Antigen Testing Kit, by Sample USD Million (2020-2025)
  • Table 228. Italy Rapid Antibody and Antigen Testing Kit, by End Use USD Million (2020-2025)
  • Table 229. United Kingdom Rapid Antibody and Antigen Testing Kit, by Components USD Million (2020-2025)
  • Table 230. United Kingdom Rapid Antibody and Antigen Testing Kit, by Disease USD Million (2020-2025)
  • Table 231. United Kingdom Rapid Antibody and Antigen Testing Kit, by Sample USD Million (2020-2025)
  • Table 232. United Kingdom Rapid Antibody and Antigen Testing Kit, by End Use USD Million (2020-2025)
  • Table 233. Netherlands Rapid Antibody and Antigen Testing Kit, by Components USD Million (2020-2025)
  • Table 234. Netherlands Rapid Antibody and Antigen Testing Kit, by Disease USD Million (2020-2025)
  • Table 235. Netherlands Rapid Antibody and Antigen Testing Kit, by Sample USD Million (2020-2025)
  • Table 236. Netherlands Rapid Antibody and Antigen Testing Kit, by End Use USD Million (2020-2025)
  • Table 237. Rest of Europe Rapid Antibody and Antigen Testing Kit, by Components USD Million (2020-2025)
  • Table 238. Rest of Europe Rapid Antibody and Antigen Testing Kit, by Disease USD Million (2020-2025)
  • Table 239. Rest of Europe Rapid Antibody and Antigen Testing Kit, by Sample USD Million (2020-2025)
  • Table 240. Rest of Europe Rapid Antibody and Antigen Testing Kit, by End Use USD Million (2020-2025)
  • Table 241. MEA Rapid Antibody and Antigen Testing Kit, by Country USD Million (2020-2025)
  • Table 242. MEA Rapid Antibody and Antigen Testing Kit, by Components USD Million (2020-2025)
  • Table 243. MEA Rapid Antibody and Antigen Testing Kit, by Disease USD Million (2020-2025)
  • Table 244. MEA Rapid Antibody and Antigen Testing Kit, by Sample USD Million (2020-2025)
  • Table 245. MEA Rapid Antibody and Antigen Testing Kit, by End Use USD Million (2020-2025)
  • Table 246. Middle East Rapid Antibody and Antigen Testing Kit, by Components USD Million (2020-2025)
  • Table 247. Middle East Rapid Antibody and Antigen Testing Kit, by Disease USD Million (2020-2025)
  • Table 248. Middle East Rapid Antibody and Antigen Testing Kit, by Sample USD Million (2020-2025)
  • Table 249. Middle East Rapid Antibody and Antigen Testing Kit, by End Use USD Million (2020-2025)
  • Table 250. Africa Rapid Antibody and Antigen Testing Kit, by Components USD Million (2020-2025)
  • Table 251. Africa Rapid Antibody and Antigen Testing Kit, by Disease USD Million (2020-2025)
  • Table 252. Africa Rapid Antibody and Antigen Testing Kit, by Sample USD Million (2020-2025)
  • Table 253. Africa Rapid Antibody and Antigen Testing Kit, by End Use USD Million (2020-2025)
  • Table 254. North America Rapid Antibody and Antigen Testing Kit, by Country USD Million (2020-2025)
  • Table 255. North America Rapid Antibody and Antigen Testing Kit, by Components USD Million (2020-2025)
  • Table 256. North America Rapid Antibody and Antigen Testing Kit, by Disease USD Million (2020-2025)
  • Table 257. North America Rapid Antibody and Antigen Testing Kit, by Sample USD Million (2020-2025)
  • Table 258. North America Rapid Antibody and Antigen Testing Kit, by End Use USD Million (2020-2025)
  • Table 259. United States Rapid Antibody and Antigen Testing Kit, by Components USD Million (2020-2025)
  • Table 260. United States Rapid Antibody and Antigen Testing Kit, by Disease USD Million (2020-2025)
  • Table 261. United States Rapid Antibody and Antigen Testing Kit, by Sample USD Million (2020-2025)
  • Table 262. United States Rapid Antibody and Antigen Testing Kit, by End Use USD Million (2020-2025)
  • Table 263. Canada Rapid Antibody and Antigen Testing Kit, by Components USD Million (2020-2025)
  • Table 264. Canada Rapid Antibody and Antigen Testing Kit, by Disease USD Million (2020-2025)
  • Table 265. Canada Rapid Antibody and Antigen Testing Kit, by Sample USD Million (2020-2025)
  • Table 266. Canada Rapid Antibody and Antigen Testing Kit, by End Use USD Million (2020-2025)
  • Table 267. Mexico Rapid Antibody and Antigen Testing Kit, by Components USD Million (2020-2025)
  • Table 268. Mexico Rapid Antibody and Antigen Testing Kit, by Disease USD Million (2020-2025)
  • Table 269. Mexico Rapid Antibody and Antigen Testing Kit, by Sample USD Million (2020-2025)
  • Table 270. Mexico Rapid Antibody and Antigen Testing Kit, by End Use USD Million (2020-2025)
  • Table 271. Research Programs/Design for This Report
  • Table 272. Key Data Information from Secondary Sources
  • Table 273. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Rapid Antibody and Antigen Testing Kit: by Components USD Million (2014-2019)
  • Figure 5. Global Rapid Antibody and Antigen Testing Kit: by Disease USD Million (2014-2019)
  • Figure 6. Global Rapid Antibody and Antigen Testing Kit: by Sample USD Million (2014-2019)
  • Figure 7. Global Rapid Antibody and Antigen Testing Kit: by End Use USD Million (2014-2019)
  • Figure 8. South America Rapid Antibody and Antigen Testing Kit Share (%), by Country
  • Figure 9. Asia Pacific Rapid Antibody and Antigen Testing Kit Share (%), by Country
  • Figure 10. Europe Rapid Antibody and Antigen Testing Kit Share (%), by Country
  • Figure 11. MEA Rapid Antibody and Antigen Testing Kit Share (%), by Country
  • Figure 12. North America Rapid Antibody and Antigen Testing Kit Share (%), by Country
  • Figure 13. Global Rapid Antibody and Antigen Testing Kit share by Players 2019 (%)
  • Figure 14. Global Rapid Antibody and Antigen Testing Kit share by Players (Top 3) 2019(%)
  • Figure 15. Global Rapid Antibody and Antigen Testing Kit share by Players (Top 5) 2019(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 18. Abbott Laboratories (United States) Revenue: by Geography 2019
  • Figure 19. Thermo Fisher Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 20. Thermo Fisher Scientific (United States) Revenue: by Geography 2019
  • Figure 21. BioMedomics, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 22. BioMedomics, Inc. (United States) Revenue: by Geography 2019
  • Figure 23. SD Biosensor, Inc. (South Korea) Revenue, Net Income and Gross profit
  • Figure 24. SD Biosensor, Inc. (South Korea) Revenue: by Geography 2019
  • Figure 25. Oxford Biomedica (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 26. Oxford Biomedica (United Kingdom) Revenue: by Geography 2019
  • Figure 27. BioLab Sciences (United States) Revenue, Net Income and Gross profit
  • Figure 28. BioLab Sciences (United States) Revenue: by Geography 2019
  • Figure 29. CTK Biotech, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 30. CTK Biotech, Inc. (United States) Revenue: by Geography 2019
  • Figure 31. Roche Holding AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 32. Roche Holding AG (Switzerland) Revenue: by Geography 2019
  • Figure 33. R-Biopharm AG (Germany) Revenue, Net Income and Gross profit
  • Figure 34. R-Biopharm AG (Germany) Revenue: by Geography 2019
  • Figure 35. Celltrion (South Korea) Revenue, Net Income and Gross profit
  • Figure 36. Celltrion (South Korea) Revenue: by Geography 2019
  • Figure 37. Global Rapid Antibody and Antigen Testing Kit: by Components USD Million (2020-2025)
  • Figure 38. Global Rapid Antibody and Antigen Testing Kit: by Disease USD Million (2020-2025)
  • Figure 39. Global Rapid Antibody and Antigen Testing Kit: by Sample USD Million (2020-2025)
  • Figure 40. Global Rapid Antibody and Antigen Testing Kit: by End Use USD Million (2020-2025)
  • Figure 41. South America Rapid Antibody and Antigen Testing Kit Share (%), by Country
  • Figure 42. Asia Pacific Rapid Antibody and Antigen Testing Kit Share (%), by Country
  • Figure 43. Europe Rapid Antibody and Antigen Testing Kit Share (%), by Country
  • Figure 44. MEA Rapid Antibody and Antigen Testing Kit Share (%), by Country
  • Figure 45. North America Rapid Antibody and Antigen Testing Kit Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Abbott Laboratories (United States)
  • Thermo Fisher Scientific (United States)
  • BioMedomics, Inc. (United States)
  • SD Biosensor, Inc. (South Korea)
  • Oxford Biomedica (United Kingdom)
  • BioLab Sciences (United States)
  • CTK Biotech, Inc. (United States)
  • Roche Holding AG (Switzerland)
  • R-Biopharm AG (Germany)
  • Celltrion (South Korea)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation